SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CNSI Cambridge Neuroscience
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: limit who wrote (532)1/27/2000 6:49:00 PM
From: Mike McFarland  Read Replies (1) of 675
 
*Off topic*
It is so nice to be asked for ones opinion,
but no, I do not have any thoughts on TCLN.
I'd surf through the thread and if you see
any comments for the biogurus here on SI,
that might give you a signal.

The only biotech I really want to 'pound the
table on' of late is GZMO--you might check it
out and buy if you see a dip, or buy without
the dip and wait a couple years.

The CEO of TGEN should have appeared in front of
a Senate committee regarding gene therapy, investors
are nervous after the sad Upenn event. Maybe if
the senators like Ms Parker they can call their
brokers, heheh.

TGEN's vector is supposed to be non-immunogenic, and
although it can't carry large genes, I like Ms. Parker
and trust her management. Barrie Carter also is on
the team at TGEN and he is a respected name
in gene therapy research--I'm waiting and hoping
for good results with the CF sinusitis trial and
perhaps the annoucement of another partner soon (E1A)
That said, I understand very little of the complexities
of these vectors "E1/E4 deleted" "gutless" ??-really at a
loss--I took physics and mathmatics instead of biology
and chemistry in school, don't know a protein from a peptide:-(
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News